Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Temporal evolution of the microbiome, immune system, and epigenome with disease progression in ALS mice.

Figueroa-Romero C, Guo K, Murdock BJ, Paez-Colasante X, Bassis CM, Mikhail KA, Raue KD, Evans MC, Taubman GF, McDermott AJ, O'Brien PD, Savelieff MG, Hur J, Feldman EL.

Dis Model Mech. 2019 Oct 9. pii: dmm.041947. doi: 10.1242/dmm.041947. [Epub ahead of print]

2.

Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes.

Hinder LM, Sas KM, O'Brien PD, Backus C, Kayampilly P, Hayes JM, Lin CM, Zhang H, Shanmugam S, Rumora AE, Abcouwer SF, Brosius FC 3rd, Pennathur S, Feldman EL.

Sci Rep. 2019 Jan 29;9(1):881. doi: 10.1038/s41598-018-37376-y.

3.

Juvenile murine models of prediabetes and type 2 diabetes develop neuropathy.

O'Brien PD, Hinder LM, Rumora AE, Hayes JM, Dauch JR, Backus C, Mendelson FE, Feldman EL.

Dis Model Mech. 2018 Dec 18;11(12). pii: dmm037374. doi: 10.1242/dmm.037374.

4.

Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story.

Hinder LM, Murdock BJ, Park M, Bender DE, O'Brien PD, Rumora AE, Hur J, Feldman EL.

Exp Neurol. 2018 Jul;305:33-43. doi: 10.1016/j.expneurol.2018.03.011. Epub 2018 Mar 14.

5.

Obesity and the nervous system: more questions - Authors' reply.

Callaghan BC, O'Brien PD, Hinder LM, Feldman EL.

Lancet Neurol. 2017 Oct;16(10):774. doi: 10.1016/S1474-4422(17)30293-4. Epub 2017 Sep 12. No abstract available.

PMID:
28920882
6.

Neurological consequences of obesity.

O'Brien PD, Hinder LM, Callaghan BC, Feldman EL.

Lancet Neurol. 2017 Jun;16(6):465-477. doi: 10.1016/S1474-4422(17)30084-4. Review.

7.

Dietary reversal of neuropathy in a murine model of prediabetes and metabolic syndrome.

Hinder LM, O'Brien PD, Hayes JM, Backus C, Solway AP, Sims-Robinson C, Feldman EL.

Dis Model Mech. 2017 Jun 1;10(6):717-725. doi: 10.1242/dmm.028530. Epub 2017 Apr 5.

8.

Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice.

O'Brien PD, Hinder LM, Parlee SD, Hayes JM, Backus C, Zhang H, Ma L, Sakowski SA, Brosius FC 3rd, Feldman EL.

Diabetes Obes Metab. 2017 Oct;19(10):1468-1472. doi: 10.1111/dom.12950. Epub 2017 Jun 2.

9.

Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns.

Hur J, O'Brien PD, Nair V, Hinder LM, McGregor BA, Jagadish HV, Kretzler M, Brosius FC 3rd, Feldman EL.

Diabetologia. 2016 Jun;59(6):1297-306. doi: 10.1007/s00125-016-3913-8. Epub 2016 Mar 21.

10.

Gender-specific differences in diabetic neuropathy in BTBR ob/ob mice.

O'Brien PD, Hur J, Robell NJ, Hayes JM, Sakowski SA, Feldman EL.

J Diabetes Complications. 2016 Jan-Feb;30(1):30-7. doi: 10.1016/j.jdiacomp.2015.09.018. Epub 2015 Oct 3.

11.

BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses.

O'Brien PD, Hur J, Hayes JM, Backus C, Sakowski SA, Feldman EL.

Neurobiol Dis. 2015 Jan;73:348-55. doi: 10.1016/j.nbd.2014.10.015. Epub 2014 Oct 30.

12.

Mouse models of diabetic neuropathy.

O'Brien PD, Sakowski SA, Feldman EL.

ILAR J. 2014;54(3):259-72. doi: 10.1093/ilar/ilt052. Review.

13.

ER stress in diabetic peripheral neuropathy: A new therapeutic target.

O'Brien PD, Hinder LM, Sakowski SA, Feldman EL.

Antioxid Redox Signal. 2014 Aug 1;21(4):621-33. doi: 10.1089/ars.2013.5807. Epub 2014 Feb 27. Review.

14.

Targeted mydriasis strategies for diabetic retinopathy screening clinics.

Dervan EW, O'Brien PD, Hobbs H, Acheson R, Flitcroft DI.

Eye (Lond). 2010 Jul;24(7):1207-12. doi: 10.1038/eye.2009.338. Epub 2010 Feb 5.

PMID:
20139914
15.

Endothelial keratoplasty: case selection in the learning curve.

O'Brien PD, Lake DB, Saw VP, Rostron CK, Dart JK, Allan BD.

Cornea. 2008 Dec;27(10):1114-8. doi: 10.1097/ICO.0b013e318180e58b.

PMID:
19034123
16.

Risk factors for a postoperative intraocular pressure spike after phacoemulsification.

O'Brien PD, Ho SL, Fitzpatrick P, Power W.

Can J Ophthalmol. 2007 Feb;42(1):51-5.

PMID:
17361241
17.
18.

Visual experiences during vitreous surgery under regional anesthesia: a multicenter study.

Tan CS, Mahmood U, O'Brien PD, Beatty S, Kwok AK, Lee VY, Au Eong KG.

Am J Ophthalmol. 2005 Dec;140(6):971-975.

PMID:
16376638
19.

Does extended wear of a tight necktie cause raised intraocular pressure?

Talty P, O'Brien PD.

J Glaucoma. 2005 Dec;14(6):508-10.

PMID:
16276286
20.

Patient pain during stretching of small pupils in phacoemulsification performed using topical anesthesia.

O'Brien PD, Fitzpatrick P, Power W.

J Cataract Refract Surg. 2005 Sep;31(9):1760-3.

PMID:
16246780
21.

The influence of pharmacological mydriasis on biomicroscopic evaluation of the glaucomatous optic nerve head.

O'Brien PD, Bogdan AJ, Fitzpatrick P, Beatty S.

Eye (Lond). 2005 Nov;19(11):1194-9.

PMID:
15543187
22.

Dry eye: diagnosis and current treatment strategies.

O'Brien PD, Collum LM.

Curr Allergy Asthma Rep. 2004 Jul;4(4):314-9. Review.

PMID:
15175147
23.

Risk factors for endothelial cell loss after phacoemulsification surgery by a junior resident.

O'Brien PD, Fitzpatrick P, Kilmartin DJ, Beatty S.

J Cataract Refract Surg. 2004 Apr;30(4):839-43.

PMID:
15093647
24.

Patient pain during different stages of phacoemulsification using topical anesthesia.

O'Brien PD, Fulcher T, Wallace D, Power W.

J Cataract Refract Surg. 2001 Jun;27(6):880-3.

PMID:
11408135
25.

Relation of ultrasonic backscatter and acoustic propagation properties to myofibrillar length and myocardial thickness.

O'Brien PD, O'Brien WD Jr, Rhyne TL, Warltier DC, Sagar KB.

Circulation. 1995 Jan 1;91(1):171-5.

PMID:
7805199
26.
27.
28.

Thromboembolism complicating psychiatric stupor.

O'Brien PD.

J Clin Psychiatry. 1991 Mar;52(3):137-8. No abstract available.

PMID:
2005079
29.

Bladder Rupture During ECT.

O'Brien PD, Morgan DH.

Convuls Ther. 1991;7(1):56-59.

PMID:
11941099
30.

Delayed splenic rupture.

Petri RW, O'Brien PD, Vukich DJ.

Ann Emerg Med. 1990 Nov;19(11):1302-5. No abstract available.

PMID:
2240727
31.

Essential ingredients of the hospital letter.

O'Brien PD.

Br J Hosp Med. 1989 Jul;42(1):80. No abstract available.

PMID:
2604780
32.

Evaluation of a sustained release form of phenylpropanolamine hydrochloride by urinary excretion studies.

HEIMLICH KR, MACDONNELL DR, FLANAGAN TL, O'BRIEN PD.

J Pharm Sci. 1961 Mar;50:232-7. No abstract available.

PMID:
13712885

Supplemental Content

Loading ...
Support Center